Home Biobank National Cancer Institute Improving Access to Clinical Trial Data and Specimens

National Cancer Institute Improving Access to Clinical Trial Data and Specimens

204
0
The NCTN Navigator inventory contains data from nearly 100 trials, more than 50,000 patients and more than 850,000 specimens.  See Navigator web site:
Grace Mishkin, MPH, Public Health Analyst with NCI was interviewed  by HemOnc.  She reported that “the NCTN, established in 2014, was designed to take more of a network approach to cancer trials.  Before NCTN, these trials were conducted as part of the cooperative group system that had been in place for decades.”
National Cancer Trial Network groups:
Children’s Oncology Group https://www.childrensoncologygroup.org/
Canadian Cancer Trials Group https://www.ctg.queensu.ca/
The combined group has been involved with hundreds of cancer trials.  Millions of specimens have been collected. According to Mishkin of the NCI has reported in HemOnc “they (specimens) are quite valuable because they were collected on clinical trials and are associated with considerable treatment and outcomes data that most specimen collections may not have.
View article here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.